Cowen predicts the CBD Market Could Reach $16B By 2025

Share This Article
February 25, 2019 2:57pm NYSE:MJ

cannabis stocks

From Andrew Ward: The U.S. cannabidiol market should expect to see continued gains in the years ahead, according to Cowen.


What Happened

The CBD market could represent a $16-billion opportunity by 2025, according to a report issued Monday by a team of Cowen analysts.

The findings are based on a roughly 40-percent increase in consumer incidence with the average user spending $640 — or less than $2 per day — each year.

To generate its findings, Cowen convened 11 of its analysts in its consumer, health care, industrials and regulatory teams to analyze the market; 2,500 consumers were surveyed to determine the findings. The report noted a higher than expected amount of CBD consumption.

“We were surprised to see that nearly 7 percent of respondents in January 2019 reported using CBD as a supplement,” the report said. This was the first month of data and findings could fluctuate, Cowen said.

Hemp — and its non-psychoactive derivative CBD — were federally legalized with the signing of the Farm Bill in January, but CBD-infused food remains illegal in the eyes of the federal government.

Why It’s Important

The analysts compared CBD to another craze: JUUL vapes.

“Indeed, to put the 6.9-percent incidence rate in context, that compares to JUUL use of 4.2 percent, and 19.6 percent of consumers that consider themselves a current tobacco user, per our survey.”

Much of Cowen’s estimations are conservative, according to the research firm.

This includes a belief that CBD use will grow 10 percent among adults, totaling around 25 million consumers by 2025.

The conservatism extends to the $16-billion forecast itself, the analysts said: “We can envision a scenario where a consumer that uses a CBD tincture or capsule may also be inclined to convert his or her beauty regimen to include CBD (e.g., CBD infused beauty products), and/or use a topical for targeted relief as well.”

What’s Next

Dissecting the industry a bit more, Cowen said it anticipates health and wellness to lead the market, with nutraceuticals earning $6.4 billion and topicals generating another $4 million. Smaller markets like food, beverages, beauty and vapor are all expected to have sales between $1 billion and $2.5 billion in the same time frame, in the sell-side firm’s view.


The ETFMG Alternative Harvest ETF (MJ) was trading at $36.19 per share on Monday afternoon, down $0.35 (-0.96%). Year-to-date, MJ has gained 11.27%, versus a 5.43% rise in the benchmark S&P 500 index during the same period.

MJ currently has an ETF Daily News SMART Grade of C (Neutral), and is ranked #59 of 75 ETFs in the Global Equities ETFs category.


This article is brought to you courtesy of Benzinga.


9 "Must Own" Growth Stocks For 2019

Read Next



Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular



Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories